|
STX17 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63447033685316E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.85590431911464E-11 |
| Normal-vs-Stage2 |
6.66499999968373E-07 |
| Normal-vs-Stage3 |
3.69682062739685E-12 |
| Normal-vs-Stage4 |
7.66553487352439E-12 |
| Stage1-vs-Stage2 |
6.688400E-01 |
| Stage1-vs-Stage3 |
2.500000E-02 |
| Stage1-vs-Stage4 |
2.100100E-03 |
| Stage2-vs-Stage3 |
2.797800E-01 |
| Stage2-vs-Stage4 |
4.394100E-02 |
| Stage3-vs-Stage4 |
2.224600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.4210854715202E-14 |
| Normal-vs-AfricanAmerican |
4.358000E-04 |
| Normal-vs-Asian |
2.18940000018542E-07 |
| Caucasian-vs-AfricanAmerican |
3.088600E-01 |
| Caucasian-vs-Asian |
5.442000E-01 |
| AfricanAmerican-vs-Asian |
6.077600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.1756819396378E-12 |
| Normal-vs-Female |
1.90092386276319E-12 |
| Male-vs-Female |
3.445600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.74979969087042E-10 |
| Normal-vs-Age(41-60Yrs) |
2.58315591139535E-12 |
| Normal-vs-Age(61-80Yrs) |
3.90476539990914E-12 |
| Normal-vs-Age(81-100Yrs) |
4.26370000000675E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.049800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.820000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.918500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.511000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.638100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.062000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.398000E-03 |
| Classical-VS-Follicular |
5.543800E-01 |
| Classical-VS-Other |
5.448000E-01 |
| Classical-VS-Normal |
8.3644999815391E-09 |
| Tall-VS-Follicular |
2.903600E-03 |
| Tall-VS-Other |
3.835800E-01 |
| Tall-VS-Normal |
5.35480548791156E-11 |
| Follicular-VS-Other |
4.867000E-01 |
| Follicular-VS-Normal |
5.12790000017915E-07 |
| Other-VS-Normal |
3.836100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.06590292148212E-11 |
| Normal-vs-N1 |
7.07369995911478E-09 |
| N0-vs-N1 |
2.872400E-01 |
|
|
